CCL2 and neoplasm: Compared with conventional anti-MSLN CAR-T cells, CAR-T cells coexpressing CCR2b exhibited increased CCL2-induced calcium flux and transport, increased levels of IL-2, IFN-γ, and TNF-α, and enhanced cytotoxicity against MSLN+ tumor cells in vitro.